Skip to main content
. 2021 Sep 30;16(9):e0257856. doi: 10.1371/journal.pone.0257856

Fig 3. Comparison of selected metabolites from significantly enriched metabolic sub-pathways.

Fig 3

Selected metabolites were important drivers of metabolic sub-pathway enrichment and varied significantly between cats with EPI and healthy controls. A. 10-heptadecenoate (17:1n7), long chain fatty acid; B. docosapentanoate (DPA, 22:5n3), polyunsaturated fatty acid; C. mevalonolactone, mevalonate metabolism; D. N-linolenoyltaurine, endocannabinoid; E. 15-methylpalmitate, branched fatty acid; F. palmitoyl-oleoyl-glycerol (16:0/18:1), diacyclglycerol; G. 1, 2-dilinoleoyl-GPE (18:2/18:2), phophatidylethanolamine.